Clinical Trials Browser

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06620835 2025-07-29

OPTALK

Phase 2 Recruiting

45 enrolled

Thoracic

Lung Neoplasms

NCT06967532 2025-05-13

TTV in NSCLC

Recruiting

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06341387 2024-04-02

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

Unknown

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT05766046 2024-03-26

RISP

Phase NA Recruiting

7,324 enrolled

Thoracic

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT03645317 2021-08-02

ACCOLADE

Phase NA Unknown

200 enrolled

Thoracic

Lung Neoplasms

NCT02839681 2019-05-21

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Phase 2 Terminated

2 enrolled 12 charts

Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

NCT01604642 2018-04-02

Role of Activin A (ActA) in the Human Cancer Cachexia

Phase NA Completed

150 enrolled

GastrointestinalThoracic

Lung Neoplasms, Colorectal Neoplasms

NCT01687647 2014-04-09

AMORCE-CBP

Phase 3 Unknown

1,000 enrolled

Thoracic

Lung Neoplasms

NCT02090166 2014-03-18

EDLC

Phase NA Unknown

950 enrolled

Thoracic

Lung Neoplasms

Clinical Trials

CCANED-CIPHER

OPTALK

TTV in NSCLC

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

RISP

ACCOLADE

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Role of Activin A (ActA) in the Human Cancer Cachexia

AMORCE-CBP

EDLC